The starting dose should be appropriate to the severity of the disease. The dose should be titrated down to the lowest dose at which effective control of asthma is maintained.

No evidence of impairment of fertility occurred in fertility studies in male and female rats at subcutaneous doses of fluticasone propionate up to 50 mcg/kg/day (approximately 6 times the human exposure associated with the maximum recommended daily inhaled dose of 500 mcg twice daily (110 pg/mL), based on rat plasma levels of approximately 650 pg/mL). If patients find that relief with short-acting bronchodilator treatment becomes less effective or they need more inhalations than usual, medical attention must be sought. Many children's asthma will be well controlled using the 50 to 100 microgram twice daily dosing regime. For those patients whose asthma is not sufficiently controlled, additional benefit may be obtained by increasing the dose up to 200 micrograms twice daily. Vaccines DHP, KC, FeLV, RCP, Myxo RHD PLUS. Vaccinations can include primary three-course (at 8, 12 and 16 weeks), lapsed restart course, boosters excluding rabies. There have been very rare reports of increases in blood glucose levels, in patients with or without a history of diabetes mellitus (see section 4.8). This should be considered in particular when prescribing to patients with a history of diabetes mellitus.As with other inhalation therapy, paradoxical bronchospasm may occur with an immediate increase in wheezing after dosing. Flixotide Evohaler should be discontinued immediately, the patient assessed and alternative therapy instituted if necessary. Not all pet insurance is the same – there are many different types of policy available, and the level of cover they provide varies.

Sometimes, the cheapest insurance can cost you more in the long run, and some policies won’t cover senior pets. Spend some time doing your research to make sure the cover you get is right for your pet. Questions to ask yourself when choosing a policyThe management of asthma should follow a stepwise programme, and patient response should be monitored clinically and by lung function tests.

As with all inhaled corticosteroids, special care is necessary in patients with active or quiescent pulmonary tuberculosis.

Objectives

The transfer of oral steroid-dependent patients to Flixotide Evohaler and their subsequent management needs special care as recovery from impaired adrenocortical function, caused by prolonged systemic steroid therapy, may take a considerable time.